Technology | Interventional Radiology | October 28, 2019

Canon Medical Offers New Affordable Interventional Technology

Alphenix Aero Edition provides greater accessibility to premium interventional imaging technology

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

October 28, 2019 — Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from imaging vendors. The Alphenix Aero Edition from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The new platform empowers vascular specialists to exercise more control over the patient experience and quality of care, while increasing their productivity and offering the opportunity to capture a more significant source of revenue. Available in the Alphenix Core + (Alphenix Core + Aero Edition) or Alphenix Sky (Alphenix Sky Aero Edition) configurations with the option for a 12 x 12 or 12 x 16 flat panel detectors (FPD), the technology delivers images with clarity and precision and combines industry-leading dose optimization technologies with a powerful workstation and tableside tablet for enhanced workflow to provide patients with accurate and fast imaging. Additionally, the platform is scalable, allowing clinicians to apply certain future upgrades as their practice evolves.

“While hospitals get busier and reimbursement rates continue to change, the Alphenix Aero Packages fit an unmet need in the healthcare space, enabling OBLs to grow their businesses and ensuring all physicians have access to the latest technology to deliver clinical excellence at a feasible budget,” said Kristin Jones, acting managing director, Vascular Business Unit, Canon Medical Systems USA, Inc. “Canon Medical’s flexible solutions open doors for customers, and encourage innovation by providing access to clinical opportunity and expansion they wouldn’t otherwise have access to.”

Alphenix is part of Canon Medical’s suite of collaborative imaging tools which puts integrated imaging intelligence at the center of a patient’s journey. The initiative fuses multiple diagnostic imaging modalities with leading clinical applications to deliver holistic, optimized patient information to clinicians at the point of care.

For more information: https://us.medical.canon

 

Related Content

myExam Companion user interface on both systems helps technologists of every experience level achieve consistently high image quality
News | Digital Radiography (DR) | January 25, 2021
January 25, 2021 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

The ulrich CTmotion

Feature | Contrast Media Injectors | January 20, 2021 | By Melinda Taschetta-Millane
According to a new...
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
Volpara Health announced two new research studies using AI-powered software to score breast density objectively and consistently to evaluate its impact in mammography and breast cancer risk assessment.
News | Breast Density | December 30, 2020
December 30, 2020 — Volpara Health announced two new research studies using...
Company delivers on last year’s roadmap milestones and continues to advance cloud-native suite of tools to lead industry to the future of enterprise imaging
News | Enterprise Imaging | December 23, 2020
December 23, 2020 — ...
 EvoHealth, a trailblazer in incorporating new technology in healthcare IT software, announced it has exceeded its first milestone of more than 100 customers with over 200 locations.
News | Information Technology | December 22, 2020
December 22, 2020 — EvoHealth, a trailblazer in incorporating n